期刊文献+

多普勒Tei指数在心脏再同步化治疗疗效评价中的作用研究

Doppler Tei index in evaluation of efficacy of cardiac resynchronization therapy
下载PDF
导出
摘要 目的研究左右心室Tei指数在心脏再同步化治疗(CRT)疗效评价中的作用。方法选取36例接受CRT手术的慢性心力衰竭患者。随访超声心动图参数,根据术前和术后6个月随访的左心室收缩末期容积缩小百分比将患者分为有反应组和无反应组,分析两组的左右心室Tei指数变化情况。结果有反应组20例,无反应组16例。有反应组左心室Tei指数在术后1周及6个月后较术前差异有统计学意义(均P<0.01)。而无反应组中左心室Tei指数术后较术前差异无统计学意义(P>0.05)。有反应组右心室Tei指数在术后1周及术后6个月较术前差异有统计学意义(均P<0.01),而无反应组术后无明显改善(P>0.05)。结论 CRT术前有反应组患者左心室Tei指数较高而术后呈现显著而持续的改善,可将Tei指数作为对CRT有反应的预测因子。CRT对左心室功能的改善间接导致了右心功能的改善。 Objective To assess the application of Doppler Tel index in evaluation of the efficacy of cardiac resynchro- nization therapy (CRT) in patients with chronic cardiac failure. Methods Thirty six patients with heart failure who underwent CRT were enrolled in the study. The patients were followed up for 6 months, if the left ventricular end-systolic volume (LVESV) was de- creased than the baseline value by 〉 10%, the patient was classified as responder. Doppler echocardiography was performed before and 1 week, 6 months after CRT; the changes of LV and RV Tel index were analyzed in responders and non-responders. Results There were 20 responders and 16 non-responders for CRT. The LV and RV Tel indexes in responders were improved significantly at 1 week and 6-month after CRT, compared with the baseline (P〈0.01); while there were no improvement in LV and RV Tel index in non-respenders. Conclusion Patients with higher LV Tel index at baseline may achieve a sustained improvement after CRT, suggesting that the baseline Tel index can be used as a predictor for CRT response in patients with chronic heart fail- ure.
出处 《浙江医学》 CAS 2014年第6期482-484,共3页 Zhejiang Medical Journal
基金 浙江省医药卫生科技计划项目(2012KYA003)
关键词 心脏再同步化治疗多普勒Tei指数心室功能 Cardiac resynchronization therapy Doppler Tei index Ventricular function
  • 相关文献

参考文献8

  • 1Wikstrom G,lomstr5m-Lijndqvist C, Andren B, et al. The effectsof aetiology on outcome in patients treated with cardiac resyn-chronization therapy in the CARE-HF trial[J], Eur Heart J, 2009, 30(7):782-788.
  • 2沈法荣,金宏义,黄抒伟,沈亚平,凌峰,陈建明.冠状窦起搏电极的临床应用[J].浙江医学,2000,22(5):259-261. 被引量:2
  • 3Yu C M, Bleeker G B, Fung J W, et al. Left ventricular reverse re-modeling but not clinical improvement predicts long-term survivalafter cardiac resynchronization therapy[J]. Circulation, 2005,112(9):1580-1586.
  • 4何浪,王志军,金红峰,钟诚,孙国建,陈建明,沈法荣.心脏再同步化治疗患者术后反应的比较研究[J].浙江医学,2011,33(11):1596-1598. 被引量:2
  • 5Nishimura R A, Hayes D L, Holmes D R, et al. Mechanism ofhemodynamic improvement by dualchamber pacing for severeleft ventricular dysfunction;an acute Doppler and catheterizationhemodynamic study[J], J Am Coll Cardiol, 1995, 25(2):281 -288.
  • 6Soliman o I, Theuns D A, Geleijnse IVl L, et al. Spectra丨 putsed-wave tissue Doppler imaging iateral-to-septal delay fails to pre-dict clinical or echocardiographic outcome after cardiac resyn-chronization therapy[J], Europace, 2007,9: 113-118.
  • 7de Sisti A, Toussaint J F, Lavergne T, et al. Determinants of mor-tality in patients undergoing cardiac resynchronization therapy:baseline clinical, echocardiographic, and angioscintigraphic e~valuation prior to resynchronization[J], Pacing Clin Electrophysio!,2005,28:1260-1270.
  • 8Yu J L, Qing Z, Jeffrey W F, et al. Different Determinants of Im-provement of Early and Late Systolic Mitral Regurgitation Con-tributed after Cardiac Resynchronization Therapy[J]. Journal ofthe American Society of Echocardiography, 2010,23(11):1160-1167.

二级参考文献12

  • 1王方正,王锦志,张奎俊,明广华,姚焰,田瑞国,朱克平,陈新.冠状窦导线与三腔起搏[J].中华心律失常学杂志,1998,2(3):184-187. 被引量:19
  • 2郭继鸿.三腔心脏起搏器的临床应用[J].中华心律失常学杂志,1998,2(3):229-234. 被引量:22
  • 3Wikstrom G, Blomstrom-Lundqvist C, Andren B, et al. The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial[J]. 2009,30(7):782-788.
  • 4Cleland J G, Coletta A P, Freemantle N, et at. Clinical trials up- date from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST II [J]. Eur J Heart Fail, 2011, 13 (7):805-808.
  • 5Finlay A, McAlister, Justin Ezekowitz, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction-A systematic review[J]. JAMA, 2007, 297(22):2502-2514.
  • 6Rivero-Ayerza M, Theuns D A, Garcia-Garcia HM,et al. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials [J]. Eur Heart J, 2006,27( 22 ):2682-2688.
  • 7Moss A J, Hall W J, Cannom D S, et al. The MADIT-CRT trial investigators. Cardiac resynchronization therapy for the prevention of heart failure events[J]. N Engl J Med, 2009,361( 14): 1329-1338.
  • 8Cleland, Freemantle, Ghio, et al. Predicting the long-Term effects of cardiac resynchronization therapy on mortatity from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial [J]. J Am Colt Cardiol, 2008,52( 6 ):438-445.
  • 9Banz.Eucomed CRT Steering Committee. Cardiac resynchronization therapy (CRT) in heart failure-a model to assess the economic value of this new medical technology[J]. Value in health, 2005, 8(2): 128-139.
  • 10Mads B K, Peter T, Rikke E, et al. Very long term follow-up of cardiac resynchronization therapy: Clinical outcome and predictors of mortality[J]. European Journal of Heart Failure, 2008,10( 8 ): 796-801.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部